Eros Innovation & TMC Launch Gujarat CARES 2025, an AI in Preventive Healthcare Initiative

Eros LifeScience and the Centre for Cancer Epidemiology at Tata Memorial Centre are set to conduct a longitudinal, population-scale study designed to generate actionable insights for individuals and policymakers alike.

Eros Innovation has launched Gujarat CARES 2025, a large-scale AI in healthcare initiative, in partnership with the Centre for Cancer Epidemiology at the Tata Memorial Centre (TMC), Mumbai, aiming to advance preventive healthcare through ethical, population-level artificial intelligence.

The initiative brings together Eros LifeScience and the Centre for Cancer Epidemiology at Tata Memorial Centre to conduct a longitudinal, population-scale study designed to generate actionable insights for individuals and policymakers alike.

Dr. Rajesh Dixit, Director, Centre for Cancer Epidemiology (CCE), Tata Memorial Centre, said, “Gujarat CARES 2025 represents a major step forward in population-scale preventive health research. We are pleased to partner with Eros LifeScience and Eros GenAI, who are emerging as leaders in the application of ethical, large-scale AI to preventive healthcare. Their advanced AI platforms add a powerful new dimension to long-term epidemiological research, enabling high-quality, actionable insights for early detection, risk stratification, and prevention strategies that can meaningfully shape public health policy in India.”

Gujarat CARES 2025 has been framed within the broader shift of aligning AI in preventive health innovation with national public health priorities.

Manju Lulla, Chairperson, Eros LifeScience, said, “Every family deserves early warning, not late discovery. For decades, Eros has taken Indian stories and cinema to audiences across the world. With Eros LifeScience and Eros GenAI, we now want India to lead in something even more fundamental – keeping people healthier for longer.”

At the core of the initiative is Eros GenAI, a sovereign and ethical AI foundation-model platform trained on more than 1.5 trillion tokens drawn from structured lifestyle, behavioural, and cultural datasets.

Dr. Pankaj Chaturvedi, Director, ACTREC, said, “Tata Memorial Centre, ACTREC, and the Centre for Cancer Epidemiology are happy to work with Eros LifeScience to enable the Gujarat CARES 2025 study. As an expansion of the Indian Study of Healthy Ageing (ISHA), this research is being conducted by the Molecular Epidemiology and Population Genomics divisions of CCE across Barshi, Varanasi, and Goa.”

“The objective is to generate high-quality evidence that will support early detection strategies, personalized risk assessment, and the formulation of informed national health policies,” he added.

The platform is designed to analyse genetic, environmental, digital, and behavioural signals over time, supporting early warning systems and personalised preventive strategies.

Insights from the study will feed into Eros LifeScience’s AI Health Graph, enabling digital biomarkers, preventive health scoring, and population-level dashboards for state and national health planning.

Stay tuned for more such updates on Digital Health News